levofloxacin has been researched along with aluminum in 1 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (aluminum) | Trials (aluminum) | Recent Studies (post-2010) (aluminum) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 18,740 | 366 | 5,335 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eto, S; Goromaru, T; Hieda, Y; Kaneuji, Y; Kawamura, R; Kohama, K; Maeda, Y; Murakami, T; Shinmachi, K; Takahashi, Y | 1 |
1 other study(ies) available for levofloxacin and aluminum
| Article | Year |
|---|---|
Effect of aluminium ion on bioavailability of levofloxacin following oral administration of cilexetil ester of levofloxacin as prodrug in rats.
Topics: Administration, Oral; Aluminum; Animals; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Escherichia coli; Esters; Intestinal Absorption; Levofloxacin; Male; Microbial Sensitivity Tests; Prodrugs; Pseudomonas aeruginosa; Rats; Rats, Sprague-Dawley; Staphylococcus aureus | 2020 |